IE00BDGMC594 - Common Stock
AVADEL PHARMACEUTICALS
NASDAQ:AVDL (11/4/2024, 8:00:00 PM)
After market: 14.86 0 (0%)14.86
-0.19 (-1.26%)
Avadel Pharmaceuticals PLC is a IE-based company operating in Pharmaceuticals industry. The company is headquartered in Dublin, Dublin and currently employs 154 full-time employees. Avadel Pharmaceuticals PLC is a biopharmaceutical company. The firm's lead product, LUMRYZ, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME and MEDUSA. Its MICROPUMP technology allows for the development of modified release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.
AVADEL PHARMACEUTICALS
Block 10-1 Blanchardstown Corporate Park, Ballycoolin
DUBLIN DUBLIN D02
P: 35319015201
CEO: Gregory J. Divis
Employees: 154
Website: https://www.avadel.com/
Which stocks are moving before the opening bell on Thursday?
DUBLIN, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to...
-- LUMRYZ is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and...
– Survey data demonstrate 94% of people with narcolepsy prefer the once-nightly regimen of LUMRYZ over twice-nightly oxybate regimens – – 91% reported...
Here you can normally see the latest stock twits on AVDL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: